Skip to content

Intracoronary Thrombus Detection by Magnetic Resonance Imaging

Non-Invasive Assessment of Intracoronary Thrombosis in Patients With Acute Coronary Syndrome and Chronic Stable Angina Using Magnetic Resonance Imaging.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02776657
Enrollment
40
Registered
2016-05-18
Start date
2016-01-14
Completion date
2017-03-31
Last updated
2024-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angina Pectoris, Angina, Stable, Angina, Unstable, Myocardial Infarction

Brief summary

This study involves the use of Magnetic Resonance Imaging (MRI) to determine whether blood clots can be identified within the blood vessels supplying blood to the heart in patients with angina and who have recently suffered a heart attack.

Detailed description

The majority of heart attacks are caused as a result of small blood clots forming within the blood vessels supplying blood to the heart, obstructing blood flow to the heart muscle. Research has also shown that blood clots may form in the blood vessels of the heart without causing a heart attack. At present, blood clots may be identified by techniques used during invasive coronary angiography, but we wish to determine whether a non-invasive test (MRI scanning) can be used to detect small blood clots within the blood vessels supplying blood to the heart muscle.

Interventions

OTHERMagnetic Resonance Imaging

Each participant will undergo at least one MRI scan. A small number will be asked to undergo repeat MRI scanning at one and three months following the initial scan.

DEVICEOptical Coherence Tomography

Participants may undergo Optical Coherence Tomography (OCT) during the angiogram procedure in order to detect thrombus within the coronary arteries.

This will be performed as part of usual care and does not constitute part of the research project.

Sponsors

University of Edinburgh
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged over 18 years * Previously diagnosed coronary artery disease undergoing elective invasive angiography (Cohort 1) OR * Admitted with Acute Coronary Syndrome (ACS) diagnosed by two of the following criteria; 1. Elevation of cardiac biomarkers (high sensitivity troponin I greater than 34ng/l in men and 16ng/l in women). 2. Symptoms of myocardial ischaemia 3. Electrocardiogram (ECG) changes indicative of acute ischaemia (Cohort 2) * Planned invasive coronary angiography

Exclusion criteria

* Contraindication or inability to undergo MRI scanning * Renal failure (estimated glomerular filtration rate less than 30millilitres/minute) * Undergoing Primary Percutaneous Coronary Intervention * Ongoing myocardial ischaemia or dynamic ECG changes * Inability to provide informed consent * Known allergy to gadolinium based contrast * Women who are pregnant, breastfeeding or of child-bearing potential

Design outcomes

Primary

MeasureTime frame
Evidence of high intensity signals within the coronary arteries on T1 weighted magnetic resonance imaging.Within 72 hours prior to angiography

Secondary

MeasureTime frame
The correlation between high risk plaques as determined on MRI with culprit plaques on invasive angiography in patients with acute coronary syndrome (ACS).Through study completion, an average of 1 year
Incidence of intracoronary thrombosis, as detected by magnetic resonance imaging, in patients with stable coronary artery disease.Through study completion, an average of 1 year
The change in plaque signal intensity on magnetic resonance imaging at one month following acute coronary syndrome (ACS).Baseline and 1 month
The change in plaque signal intensity on magnetic resonance imaging at three months following acute coronary syndrome (ACS).Baseline and 3 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026